• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
The Tregs as Medicine Symposium | Advances in Tolerance Research

The Tregs as Medicine Symposium | Advances in Tolerance Research

by Elena Iemma | Aug 19, 2025 | Blog

The Tregs as Medicine Symposium September 26, 2025 | The Westin Hotel, Meguro Tokyo The Tregs as Medicine: Tolerance and InTolerance Symposium will bring together leading scientists and clinicians to examine how regulatory T cells (Tregs) and tolerance...
International Conference on Therapeutic Antibodies in Mexico – November 29th-30th, 2018 (Updated)

International Conference on Therapeutic Antibodies in Mexico – November 29th-30th, 2018 (Updated)

by Annie De Groot | Nov 6, 2018 | Events

2nd International Conference on Therapeutic Antibodies in Mexico Thursday, November 29th and Friday, November 30th Hotel Hilton Reforma, CDMX We had a great time at this event! Check out photos from the seminar below. Annie De Groot – CEO/CSO, EpiVax Rob Etches...

Recent Posts

  • The Power of Tregs: From Sakaguchi’s Nobel Discovery to EpiVax Innovation
  • The Tregs as Medicine Symposium | Advances in Tolerance Research
  • Optimize Your Immunogenicity Strategy with Trusted Expert Advice 
  • Tregs, Epitopes, and the Future of Immune Tolerance
  • The Platinum Vaccine & Change is Good!

Recent Comments

No comments to show.

Join our newsletter

Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.